Lord Alton of Liverpool – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Lord Alton of Liverpool on 2016-02-22.
To ask Her Majesty’s Government, further to the Written Answers by Lord Prior of Brampton on 11 February (HL5773, HL5959 and HL5960), why they have not placed in the Library of the House a full copy of the original licence application submitted to the Human Fertilisation and Embryology Authority (HFEA) to perform genome editing in human embryos by means of CRISPR-Cas9; why they have not placed in the Library of the House copies of the patient information and consent forms submitted to the HFEA by the person responsible in order to perform such work; how the conditions stipulated under paragraph 13 of Section G in Direction 0008 version 4 as published by HFEA on 29 October 2015 (http://www.hfea.gov.uk/docs/ General_Directions_0008. pdf) regarding Information to be submitted to the HFEA as part of the licensing process” were satisfied in the case of the decision; and why they will not place in the Library of the House a full copy of the responses to peer reviewers by the person responsible.”
Lord Prior of Brampton
The Human Fertilisation and Embryology Authority (HFEA) publishes on its website the inspection report relating to a licence renewal application and the minutes of the Licence Committee’s decision. It does not publish other information associated with a licence application.
The Licence Committee considering the application to which the noble Lord refers was satisfied that the requirements of General Directions 0008 were met, with the exception of evidence of ethics approval, which must be submitted to the HFEA before any licensed research can begin.
The HFEA has advised that licence conditions R18-R27 and T97 address any potential conflict between the use of embryos in research and the use of embryos in the provision of treatment services. The person responsible did not give a reason on the application form for requesting that reference to surplus embryos should be removed from the research project title, nor are they required to do so. The removal of ‘surplus’ from the title does not reflect a change in the way embryos will be donated to the research.
